{"id":"W2254789682","doi":"10.1155/2002/493296","title":"The Addition of Salmeterol 50 µg Bid to Anticholinergenic Treatment in Patients with COPD: A Randomized Placebo Controlled Trial","year":2002,"lang":"en","type":"article","venue":"Canadian Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"GlaxoSmithKline","keywords":"Salmeterol; Medicine; COPD; Placebo; Anticholinergic; Bronchodilator; Randomized controlled trial; Anesthesia; Internal medicine; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008321228,0.0002249347,0.0008606322,0.000685258,0.0002188468,0.00004905646,0.0001632876,0.00008502427,0.001132484],"category_scores_gemma":[0.0007678502,0.000133268,0.0002796073,0.0003421911,0.0001952875,0.00008822882,0.00001186609,0.0003235883,0.00003432042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001590717,"about_ca_system_score_gemma":0.001539366,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001332355,"about_ca_topic_score_gemma":0.009927752,"domain_scores_codex":[0.9971545,0.0006906653,0.0007331306,0.0002403865,0.0006069095,0.0005743563],"domain_scores_gemma":[0.9975379,0.0003746157,0.0002377328,0.0003435296,0.0003410864,0.001165099],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9744729,0.0003554635,0.01032489,0.00001622804,0.0004601583,0.0002345483,0.0001222816,0.00004309058,0.00003883644,0.00001691606,0.003545086,0.01036962],"study_design_scores_gemma":[0.9526812,0.001761155,0.03121081,0.0001045649,0.0002017814,0.00001703366,0.00005243236,0.0002066896,0.00001804787,0.00001311368,0.01359941,0.0001337907],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909873,0.001297742,0.000009203098,0.0006840065,0.0002447755,0.005604286,0.00009835837,0.000006903015,0.001067416],"genre_scores_gemma":[0.998089,0.00007181126,0.00003452618,0.0006016885,0.0003292833,0.0003862731,0.00001140317,0.00003583784,0.0004402072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02179171,"threshold_uncertainty_score":0.9997806,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0183407024204525,"score_gpt":0.2638323017331758,"score_spread":0.2454915993127234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}